Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001918704-26-012431 <b>Size:</b> 1 MB

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001839882-26-023255 <b>Size:</b> 683 KB

(30% Negative) SIX FLAGS ENTERTAINMENT CORPORATION/NEW (FUN) Reports Q2 2026 Financial Results

Americold Realty Trust, Inc. and EQT Announce a $1.3 Billion North American Cold Storage Joint Venture USA - English USA - English

(99% Neutral) NUVEEN CHURCHILL DIRECT LENDING CORP. COMMON STOCK (NCDL) Reports Q2 2026 Financial Results

(30% Negative) BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Reports Q2 2026 Financial Results

enGene Announces Updated Interim Results From LEGEND Pivotal Cohort

(30% Negative) MADISON SQUARE GARDEN ENTERTAINMENT CORP. (MSGE) Reports Q2 2026 Financial Results

(69% Positive) GPGI, INC. (GPGI) Announces Business Combination

(30% Negative) XERIS BIOPHARMA HOLDINGS, INC. (XERS) Reports Q2 2026 Financial Results

(35% Negative) RESOLUTE HOLDINGS MANAGEMENT, INC. (RHLD) Reports Q2 2026 Financial Results

(99% Positive) OPPFI INC. (OPFI) Reports Q2 2026 Financial Results

(30% Negative) ACLARIS THERAPEUTICS, INC. (ACRS) Reports Q2 2026 Financial Results

(75% Positive) GP-ACT III ACQUISITION CORP. (GPATW) Announces Business Combination

(30% Negative) RAPPORT THERAPEUTICS, INC. (RAPP) Reports Q2 2026 Financial Results